Summary
Insulin sensitivity has been quantified by i. v. insulin tolerance test (0.1 U/kg of body weight) in 18 (11 male/7 female) non-obese (body mass index range 19–25 kg/m2) normoglycaemic subjects. We then compared the tyrosine kinase activity and internalization of insulin receptor in monocytes from the six most insulin-sensitive (group 1) and the six most insulin-resistant (group 3) subjects. Tyrosine kinase activity was measured on immunopurified receptors using 32P-ATP and poly-glutamic acid 4: tyrosine 1, sodium salt (poly-glu-tyr 4∶1). Insulin internalization was studied by incubating cells with 1 nmol/l 125I-insulin and measuring total cell-bound and intracellular 125I-insulin by an acid dissociation procedure. Basal (in the absence of insulin) receptor kinase activity was similar in both groups. Maximal (in the presence of 100 nmol/l insulin) kinase activity was 41% lower in group 3 (13.8±3.6 fmoles 32P-ATP incorporated vs 23.3±4.0, p=0.1). Delta increment of receptor kinase activity after insulin stimulation (calculated by subtracting basal from maximal activity) was significantly (p<0.05) reduced in group 3 (21.3±3.8 vs 11.1±2.1) and significantly (p<0.05) correlated to the in vivo insulin sensitivity. Both total cell-bound (0.70±0.09 % of total radioactivity added vs 0.83±0.15) and intracellular (0.39±0.05 vs 0.44±0.09) 125I-insulin were similar in the two groups. These data suggest that in non-obese, normoglycaemic subjects a defective insulin receptor tyrosine kinase activity may contribute to the development of insulin resistance. This raises the possibility that the reduced receptor kinase activity observed in Type 2 (non-insulin-dependent) diabetic patients may be independent from the diabetes and may in fact precede the appearance of the disease.
Article PDF
Similar content being viewed by others
References
Reaven GM (1988) Banting Lecture: role of insulin resistance in human disease. Diabetes 37: 1595–1607
DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15: 318–368
Caro JR, Ittop O, Pories WJ et al. (1986) Studies on the mechanism of insulin-resistance in the liver from humans with noninsulin-dependent diabetes. J Clin Invest 78: 249–258
Freidenberger GR, Henry RR, Klein HH, Reichart DR, Olefsky JM (1987) Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J Clin Invest 79: 240–250
Caro JF, Sinha MK, Raju SM et al. (1987) Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79: 1330–1337
Arner P, Pollare T, Lithell H, Livingstone JN (1987) Defective insulin receptor tyrosine-kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 437–440
Comi R, Grunberger C, Gorden P (1987) Relationship of insulin binding and insulin-stimulated tyrosine-kinase activity is altered in type II diabetes. J Clin Invest 79: 453–462
Jochen AL, Berhanu P, Olefsky JM (1986) Insulin internalization and degradation in adipocytes from normal and type II diabetes subjects. J Clin Endocrinol Metab 62: 268–272
Trischitta V, Gullo D, Squatrito S, Pezzino V, Goldfine ID, Vigneri R (1986) Insulin internalization into monocytes is decreased in patients with tvpe II diabetes mellitus. J Clin Endocrinol Metab 62: 522–529
Trischitta V, Brunetti A, Chiavetta A, Benzi L, Papa L, Vigneri R (1989) Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients. Diabetes. 38: 1579–1584
National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057
Bonora E, Moghetti P, Zancanaro C et al. (1989) Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 68: 374–378
Steele-Perkins G, Roth RA (1990) Insulin-mimetic anti-insulin receptor monoclonal antibodies stimulate receptor kinase activity in intact cells. J Biol Chem 265: 9458–9463
Grunberger G, Zick Y, Gorden P (1984) Defect in phosphorylation of insulin receptors in cells from an insulin-resistant patients with normal insulin binding. Science 223: 932–934
Trischitta V, Giorgino F, Frittitta L, Scalisi R, Vigneri R (1993) Relationship between insulin receptor tyrosine-kinase activity and internalization in monocytes of NIDDM patients. Metabolism 42: 882–887
Daneman D, Zinman B, Elliot ME, Bilan PS, Klip A (1992) Insulin-stimulated glucose transport in circulating mononuclear cells from nondiabetic and IDDM subjects. Diabetes 41: 227–234
Handberg A, Vaag A, Vintent J, Beck-Nielsen H (1992) Defect insulin receptor kinase activation in skeletal muscle in young non-obese first degree relatives of patients with NIDDM. Diabetes 41 [Suppl 1]: 63A (Abstract)
Taylor SI, Cama A, Accili D et al. (1992) Mutations in the insulin receptor gene. Endocrine Rev 13: 566–595
Arsenis G, Livingstone J (1986) Alterations in the tyrosine kinase activity of the insulin receptor produced by in vitro hyperinsulinemia. J Biol Chem 261: 147–153
Williams JF, Olefsky JM (1990) Defective insulin receptor function in down-regulated HEpG2 cells. Endocrinology 127: 1706–1717
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frittitta, L., Grasso, G., Munguira, M.E. et al. Insulin receptor tyrosine kinase activity is reduced in monocytes from non-obese normoglycaemic insulin-resistant subjects. Diabetologia 36, 1163–1167 (1993). https://doi.org/10.1007/BF00401061
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00401061